PRECIGEN, INC. - Amendment to Schedule 13D Filing

2026-03-31SEC Filing SCHEDULE 13D/A (0001213900-26-037403)

This filing is an amendment to the Schedule 13D for Precigen, Inc., formerly Intrexon Corporation. Randal J. Kirk, R.J. Kirk Declaration of Trust, and Third Security, LLC (collectively, the "Reporting Persons") are filing this amendment to report the sale of 4,772,781 shares of Common Stock by certain entities under their common control. The sales occurred in open market transactions on March 30, 2026, resulting in aggregate net proceeds of approximately $15,581,221. The filing details the updated ownership percentages and shareholdings of the Reporting Persons, including the impact of options and warrants. Mr. Kirk directly holds 133,956,416 shares, representing 35.9% ownership. The R.J. Kirk Declaration of Trust holds 97,339,485 shares (26.1%), and Third Security, LLC holds 21,843,458 shares (5.9%). The total outstanding shares of common stock, adjusted for recent issuances and exercisable options/warrants, are considered for ownership calculations.

Ticker mentioned:PGENInstitution mentioned:KIRK RANDAL J
Related industry:Biotechnology